Medizinische Universitat Innsbruck, Abteilung fur Neurologie

Innsbruck 6020

0 studies enrolling now · 2 studies all time

What they study most

MSA, Parkinson's Disease (PD), Pure Autonomic Failure (PAF), Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early
• Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Completed